Category Archives: Eli Lilly

Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology

Eli Lilly and Company (NYSE: LLY) and Adocia (Euronext Paris: FR0011184241 – ADOC) today announced a worldwide licensing collaboration focused on developing an ultra-rapid insulin, known as BioChaperone Lispro, for treatment in people with type 1 and type 2 diabetes.

Helping African Americans F.A.C.E. Their Risk for Diabetes

Diabetes Health publisher Nadia Al-Samarrie  spoke with television and movie actor Anthony Anderson, who has taken a lead role with Eli Lilly & Company’s F.A.C.E. campaign, a diabetes outreach to African Americans. A veteran of more than 20 films, Anthony,

BI-Lilly Alliance Creates Formidable Drug Development Combine

Pharma giants Boehringer Ingelheim (BI) and Eli Lilly and Company (Lilly) have formed the

BI-Lilly Diabetes Alliance, a joint effort, involving the development of several drugs aimed at treating type 1 and type 2 diabetes patients.

The Alliance recently showed …

Lilly to Address Humulin R U-500 Insulin Errors

Insulin prescription errors rank first among all prescribed drugs. In an effort to remedy this problem, Eli Lilly is developing a prefilled pen for delivering Humulin R U-500 insulin as well as collaborating on the development of a dedicated U-500 syringe.

This …

FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at the plant where it is manufactured are fixed.

The delay does not call into question the safety or utility of …

Kris Freeman in Sochi: Type 1 Diabetes Skier- 4th Time Olympian

I remember first seeing Kris Freeman when he was 21 at a diabetes conference. Two years after he was diagnosed with type 1 diabetes, Eli Lilly began sponsoring his dream of becoming an Olympic cross-country skier. During his off-season, you …